{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:11682"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:11682","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Evolution of the human CD4+ T cell response to Epstein-Barr virus infection - analysis of systemic and local immune responses","abstract":"CD4+ T cells are essential for overall control of human virus infections, yet their multiple roles remain ill-defined at the single cell level, and most studies have focused solely on analysis of those present in the circulation. Using Epstein-Barr virus (EBV)-specific human leukocyte antigen (HLA) class II tetramers, we have studied the circulating functional and clonal evolution of circulating antigen-specific CD4+ T cell responses during infection and analysed the CD4+ T cell response at the site of viral replication. We show that primary EBV infection, elicits an acute expansion of oligoclonal antigenspecific T helper-1 (TH1)-like CD4+ T cell populations in the blood that are armed with cytotoxic proteins and can respond immediately ex vivo to challenge with virus-infected B cells. Over time as the primary response contracts, we find that the resultant memory populations show (i) a marked decrease in cells expressing cytotoxic and activation markers, but (ii) increased TCR diversity as new clonotypes join those originally present, and (iii) increased cytokine polyfunctionality. Importantly, the cytotoxic CD4+ T cells responding to acute primary infection differed in their transcriptional program to the classically described CD4-CTLs that accumulate during chronic viral infections. Moreover, we show that EBV infection seeds populations of tissue resident EBV-specific CD4+ T cells in the tonsil. These EBV-specific TRM which expresses cytotoxic proteins, are preferentially retained in the T cell zone and B cell follicles of the tonsils. These findings imply an important effector role for CD4-CTLs in acute EBV infection and at the site of EBV replication, emphasising the need to harness their potential in herpesvirus vaccine design.","abstract_html":"CD4+ T cells are essential for overall control of human virus infections, yet their multiple roles remain ill-defined at the single cell level, and most studies have focused solely on analysis of those present in the circulation. Using Epstein-Barr virus (EBV)-specific human leukocyte antigen (HLA) class II tetramers, we have studied the circulating functional and clonal evolution of circulating antigen-specific CD4+ T cell responses during infection and analysed the CD4+ T cell response at the site of viral replication. We show that primary EBV infection, elicits an acute expansion of oligoclonal antigenspecific T helper-1 (TH1)-like CD4+ T cell populations in the blood that are armed with cytotoxic proteins and can respond immediately ex vivo to challenge with virus-infected B cells. Over time as the primary response contracts, we find that the resultant memory populations show (i) a marked decrease in cells expressing cytotoxic and activation markers, but (ii) increased TCR diversity as new clonotypes join those originally present, and (iii) increased cytokine polyfunctionality. Importantly, the cytotoxic CD4+ T cells responding to acute primary infection differed in their transcriptional program to the classically described CD4-CTLs that accumulate during chronic viral infections. Moreover, we show that EBV infection seeds populations of tissue resident EBV-specific CD4+ T cells in the tonsil. These EBV-specific TRM which expresses cytotoxic proteins, are preferentially retained in the T cell zone and B cell follicles of the tonsils. These findings imply an important effector role for CD4-CTLs in acute EBV infection and at the site of EBV replication, emphasising the need to harness their potential in herpesvirus vaccine design.","abstract_has_math":false,"creators":["Meckiff, Benjamin James"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-07","date_published":"2021-07","updated_at":"2026-11-19T09:31:28Z","subjects":["QH301 Biology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/11682/7/Meckiff2021PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A11682","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Meckiff, Benjamin James"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2021-07-21"]},{"key":"dc:date.issued","label":"Date","values":["2021-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/11682/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH301 Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/11682/7/Meckiff2021PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["CD4+ T cells are essential for overall control of human virus infections, yet their multiple roles remain ill-defined at the single cell level, and most studies have focused solely on analysis of those present in the circulation. Using Epstein-Barr virus (EBV)-specific human leukocyte antigen (HLA) class II tetramers, we have studied the circulating functional and clonal evolution of circulating antigen-specific CD4+ T cell responses during infection and analysed the CD4+ T cell response at the site of viral replication. We show that primary EBV infection, elicits an acute expansion of oligoclonal antigenspecific T helper-1 (TH1)-like CD4+ T cell populations in the blood that are armed with cytotoxic proteins and can respond immediately ex vivo to challenge with virus-infected B cells. Over time as the primary response contracts, we find that the resultant memory populations show (i) a marked decrease in cells expressing cytotoxic and activation markers, but (ii) increased TCR diversity as new clonotypes join those originally present, and (iii) increased cytokine polyfunctionality. Importantly, the cytotoxic CD4+ T cells responding to acute primary infection differed in their transcriptional program to the classically described CD4-CTLs that accumulate during chronic viral infections. Moreover, we show that EBV infection seeds populations of tissue resident EBV-specific CD4+ T cells in the tonsil. These EBV-specific TRM which expresses cytotoxic proteins, are preferentially retained in the T cell zone and B cell follicles of the tonsils. These findings imply an important effector role for CD4-CTLs in acute EBV infection and at the site of EBV replication, emphasising the need to harness their potential in herpesvirus vaccine design."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Evolution of the human CD4+ T cell response to Epstein-Barr virus infection - analysis of systemic and local immune responses"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Meckiff, Benjamin James"],"dc:date":["2021-07-21"],"dc:date.issued":["2021-07"],"dc:description.abstract":["CD4+ T cells are essential for overall control of human virus infections, yet their multiple roles remain ill-defined at the single cell level, and most studies have focused solely on analysis of those present in the circulation. Using Epstein-Barr virus (EBV)-specific human leukocyte antigen (HLA) class II tetramers, we have studied the circulating functional and clonal evolution of circulating antigen-specific CD4+ T cell responses during infection and analysed the CD4+ T cell response at the site of viral replication. We show that primary EBV infection, elicits an acute expansion of oligoclonal antigenspecific T helper-1 (TH1)-like CD4+ T cell populations in the blood that are armed with cytotoxic proteins and can respond immediately ex vivo to challenge with virus-infected B cells. Over time as the primary response contracts, we find that the resultant memory populations show (i) a marked decrease in cells expressing cytotoxic and activation markers, but (ii) increased TCR diversity as new clonotypes join those originally present, and (iii) increased cytokine polyfunctionality. Importantly, the cytotoxic CD4+ T cells responding to acute primary infection differed in their transcriptional program to the classically described CD4-CTLs that accumulate during chronic viral infections. Moreover, we show that EBV infection seeds populations of tissue resident EBV-specific CD4+ T cells in the tonsil. These EBV-specific TRM which expresses cytotoxic proteins, are preferentially retained in the T cell zone and B cell follicles of the tonsils. These findings imply an important effector role for CD4-CTLs in acute EBV infection and at the site of EBV replication, emphasising the need to harness their potential in herpesvirus vaccine design."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/11682/7/Meckiff2021PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/11682/"],"dc:subject":["QH301 Biology"],"dcterms:accessrights":["public"],"dc:title":["Evolution of the human CD4+ T cell response to Epstein-Barr virus infection - analysis of systemic and local immune responses"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:31:28Z"}